Atomoxetine is a medication primarily prescribed for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents, and adults [1]. It is a selective norepinephrine reuptake inhibitor (SNRI) [2]. The 10mg dosage is a specific formulation available for this medication.
What is Atomoxetine used for?
Atomoxetine is indicated for the treatment of ADHD [1]. It works by increasing the levels of norepinephrine, a neurotransmitter, in the brain, which can help improve focus and reduce impulsive behavior and hyperactivity [2].
How is Atomoxetine dosed?
Dosage of atomoxetine is individualized based on the patient's weight, age, and response to treatment [3]. For children and adolescents weighing less than 70 kg (154 lbs), the starting dose is typically 0.5 mg per kg per day, which can be increased after a minimum of three days to a target dose of approximately 1.2 mg per kg per day. For those weighing 70 kg or more, the starting dose is 40 mg per day, with a target dose of about 80 mg per day after a minimum of three days [3]. The 10mg strength is likely part of a titration schedule to reach the appropriate therapeutic dose.
When can patients expect to see effects from Atomoxetine?
It typically takes several weeks of consistent use for atomoxetine to show its full therapeutic effect in managing ADHD symptoms [4].
What are the common side effects of Atomoxetine?
Common side effects of atomoxetine can include upset stomach, nausea, vomiting, fatigue, decreased appetite, dizziness, and mood swings [5].
Are there serious risks associated with Atomoxetine?
In rare cases, atomoxetine has been associated with serious side effects, including liver injury, suicidal thoughts or behaviors, and cardiovascular problems such as increased heart rate or blood pressure [6]. Patients should be monitored for any unusual changes in mood, behavior, or physical health while taking this medication.
What is the patent status of Atomoxetine?
Atomoxetine, under the brand name Strattera, has been subject to patent protections. As patents expire, generic versions of the drug become available [7]. Information on specific patent expiry dates and ongoing patent litigation can be found on resources like DrugPatentWatch.com [7].
Who makes generic Atomoxetine?
Following patent expiries, various pharmaceutical companies manufacture generic versions of atomoxetine. These generics are bioequivalent to the branded product [7].
How does Atomoxetine compare to stimulant ADHD medications?
Atomoxetine is a non-stimulant medication, unlike amphetamine or methylphenidate-based treatments for ADHD [2]. This can be an important consideration for individuals who do not tolerate stimulants well or for whom stimulants are not the most effective treatment option.
Where can I find more information on Atomoxetine patents?
DrugPatentWatch.com provides detailed information on drug patents, including those for atomoxetine, and can be a valuable resource for understanding market exclusivity and generic entry timelines [7].
Sources:
1. https://www.ncbi.nlm.nih.gov/books/NBK555966/
2. https://www.nhs.uk/medicines/atomoxetine/
3. https://www.rxlist.com/strattera-drug.htm
4. https://www.mayoclinic.org/drugs-supplements/atomoxetine-oral-route/proper-use/drg-20061440
5. https://www.webmd.com/drugs/2/204057/atomoxetine-oral/details
6. https://www.drugs.com/sfx/atomoxetine-side-effects.html
7. https://drugpatentwatch.com/